BIO-key International is trading 11.38% down in pre-market at $2.58, amid risk-off sentiment after hotter-than-expected U.S. inflation weighed on equities.
- No new company-specific catalyst for the decline surfaced in the available search. The October 13 announcement of a new Middle East government security agency customer preceded the recent rally, but does not directly explain this morning’s drop.
- Reuters reporting linked the global selloff to inflation-driven rate concerns. Technology shares and Asian markets were under pressure; Nasdaq futures were down 1.11%.